Total Payments
$549.14
2022 Payments
$12.95
Companies
10
Transactions
23
Medicare Patients
5,724
Medicare Billing
$438,702
Payment Breakdown by Category
Food & Beverage$432.60 (78.8%)
Education$79.90 (14.6%)
Gifts$36.64 (6.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $432.60 | 19 | 78.8% |
| Education | $79.90 | 2 | 14.6% |
| Gift | $36.64 | 2 | 6.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $208.21 | 14 | $0 (2022) |
| Aerie Pharmaceuticals, Inc. | $113.68 | 1 | $0 (2019) |
| Shire North American Group Inc | $75.00 | 1 | $0 (2018) |
| Alcon Laboratories Inc | $39.09 | 1 | $0 (2018) |
| OPTOVUE, INC. | $23.43 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $21.08 | 1 | $0 (2018) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
| Carl Zeiss Meditec, Inc. | $17.24 | 1 | $0 (2020) |
| Sun Pharmaceutical Industries Inc. | $16.33 | 1 | $0 (2020) |
| Alcon Vision LLC | $15.68 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $12.95 | 1 | Allergan, Inc. ($12.95) |
| 2021 | $30.26 | 2 | Allergan, Inc. ($30.26) |
| 2020 | $207.32 | 13 | Allergan, Inc. ($138.67) |
| 2019 | $137.11 | 2 | Aerie Pharmaceuticals, Inc. ($113.68) |
| 2018 | $161.50 | 5 | Shire North American Group Inc ($75.00) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/21/2022 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: GLAUCOMA | ||||||
| 07/09/2021 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/12/2021 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: GLAUCOMA | ||||||
| 12/08/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/12/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/14/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/08/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: DRY EYE | ||||||
| 09/10/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/06/2020 | Allergan, Inc. | DURYSTA (Drug) | Education | In-kind items and services | $39.95 | General |
| Category: GLAUCOMA | ||||||
| 07/06/2020 | Allergan, Inc. | DURYSTA (Drug) | Education | In-kind items and services | $39.95 | General |
| Category: GLAUCOMA | ||||||
| 06/26/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: GLAUCOMA | ||||||
| 06/11/2020 | Sun Pharmaceutical Industries Inc. | BROMSITE (Drug), CEQUA, XELPROS | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: Ophthalmology | ||||||
| 05/13/2020 | Carl Zeiss Meditec, Inc. | None Specified (Medical Supply) | Gift | In-kind items and services | $17.24 | General |
| 05/12/2020 | Carl Zeiss Meditec AG | None Specified (Medical Supply) | Gift | In-kind items and services | $19.40 | General |
| 03/09/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/14/2020 | Alcon Vision LLC | Luxor (Device) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Ophthalmology | ||||||
| 08/22/2019 | OPTOVUE, INC. | OCT (Device) | Food and Beverage | Cash or cash equivalent | $23.43 | General |
| Category: Optometry | ||||||
| 05/30/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $113.68 | General |
| Category: Glaucoma | ||||||
| 10/22/2018 | Novartis Pharmaceuticals Corporation | TRAVATAN Z (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/28/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: OPTHALMICS | ||||||
| 08/13/2018 | Allergan Inc. | XEN (Device) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: GLAUCOMA | ||||||
| 04/15/2018 | Alcon Laboratories Inc | ORA (Device), ReSTOR | Food and Beverage | In-kind items and services | $39.09 | General |
| Category: Ophthalmology | ||||||
| 03/02/2018 | Allergan Inc. | XEN (Device) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: GLAUCOMA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 11 | 1,365 | 1,671 | $284,470 | $86,190 |
| 2021 | 11 | 2,247 | 2,947 | $536,950 | $181,870 |
| 2020 | 13 | 2,112 | 2,619 | $522,710 | $170,643 |
Total Patients
5,724
Total Services
7,237
Medicare Billing
$438,702
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 370 | 623 | $102,795 | $35,050 | 34.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 258 | 275 | $68,750 | $20,042 | 29.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 264 | 274 | $32,880 | $11,680 | 35.5% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 18 | 22 | $17,600 | $5,645 | 32.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 229 | 242 | $30,250 | $5,548 | 18.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 36 | 36 | $9,720 | $3,545 | 36.5% |
| 92134 | Imaging of retina | Office | 2022 | 108 | 115 | $14,375 | $2,780 | 19.3% |
| 92002 | New patient problem focused exam of visual system | Office | 2022 | 13 | 13 | $2,275 | $712.78 | 31.3% |
| 92250 | Photography of the retina | Office | 2022 | 29 | 29 | $3,625 | $695.35 | 19.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 19 | 20 | $1,100 | $343.02 | 31.2% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 21 | 22 | $1,100 | $149.53 | 13.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 444 | 923 | $152,295 | $56,419 | 37.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 506 | 592 | $148,000 | $51,847 | 35.0% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 418 | 444 | $53,280 | $20,983 | 39.4% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Office | 2021 | 65 | 77 | $62,400 | $20,919 | 33.5% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 277 | 331 | $41,375 | $9,543 | 23.1% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 77 | 77 | $20,790 | $8,667 | 41.7% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 256 | 285 | $35,625 | $7,391 | 20.7% |
| 92250 | Photography of the retina | Office | 2021 | 112 | 120 | $15,000 | $3,407 | 22.7% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2021 | 25 | 25 | $4,375 | $1,605 | 36.7% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Office | 2021 | 26 | 32 | $1,760 | $729.92 | 41.5% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2021 | 41 | 41 | $2,050 | $358.11 | 17.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 395 | 751 | $123,915 | $47,849 | 38.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 440 | 485 | $121,250 | $40,402 | 33.3% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 370 | 392 | $47,040 | $18,291 | 38.9% |
About Dr. Robert Rice, M.D
Dr. Robert Rice, M.D is a Ophthalmology healthcare provider based in Sanford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689651069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Rice, M.D has received a total of $549.14 in payments from pharmaceutical and medical device companies, with $12.95 received in 2022. These payments were reported across 23 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($432.60).
As a Medicare-enrolled provider, Rice has provided services to 5,724 Medicare beneficiaries, totaling 7,237 services with total Medicare billing of $438,702. Data is available for 3 years (2020–2022), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Sanford, ME
- Active Since 12/28/2005
- Last Updated 06/29/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1689651069
Products in Payments
- DURYSTA (Drug) $127.61
- Rhopressa (Drug) $113.68
- XIIDRA (Drug) $75.00
- LUMIGAN (Drug) $49.02
- ORA (Device) $39.09
- None Specified (Medical Supply) $36.64
- XEN (Device) $26.33
- OCT (Device) $23.43
- TRAVATAN Z (Drug) $21.08
- BROMSITE (Drug) $16.33
- Luxor (Device) $15.68
- RESTASIS (Drug) $5.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.